Focus on the Atrial Structure —Useful Anatomical Information for Catheter Ablation—
نویسندگان
چکیده
منابع مشابه
Catheter Ablation for Atrial Fibrillation
everal different approaches have been proposed for targeting the pulmonary veins (PVs) or atria in catheter ablation for atrial fibrillation (AF). It was initially focal radiofrequency (RF) application inside the PV, then PV ostial isolation by segmental RF applications guided by a circular mapping catheter was developed (EP-guided method).1 Another standard method, circumferential PV isolation...
متن کاملCatheter ablation for atrial fibrillation.
Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with associated deterioration of atrial mechanical function.1 It is the most common cardiac arrhythmia, becomes more prevalent with age,2 and is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality.3 AF can occur in the absence of underlying he...
متن کامل[Catheter ablation for atrial fibrillation].
Atrial fibrillation, the most common cardiac arrhythmia, is frequently disabling and drug-resistant, and can be associated with major complications such as thromboembolic events. Non drug approaches, including surgery and catheter-based ablation, are used to treat the most severely symptomatic patients. These new treatment strategies have drastically improved our knowledge of the pathophysiolog...
متن کاملCatheter ablation for atrial fibrillation.
n engl j med 365;24 nejm.org december 15, 2011 2296 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are pres...
متن کاملCatheter Ablation for Atrial Fibrillation
Atrial fibrillation (AF), the most common arrhythmia in adults, affects 1 in 25 people over the age of 60 years and 1 in 10 over the age of 80 years.1 There is considerable morbidity, mortality and economic burden associated with AF, all of which will increase with the expanding elderly population. Until recently, pharmacologic therapy with AV nodal blocking agents, antiarrhythmics and anticoag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Arrhythmia
سال: 2011
ISSN: 1880-4276,1883-2148
DOI: 10.4020/jhrs.27.268